Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HRas proto-oncogene, GTPase Produits

(HRas proto-oncogene, GTPase (HRAS))

Catégories

This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, mental retardation, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008].

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories HRas proto-oncogene, GTPase en vedette

HRas proto-oncogene, GTPase Anticorps

High quality antibodies with extensive validation data.

HRas proto-oncogene, GTPase Kits ELISA

Reliable ELISA kits for a wide range of species.

HRas proto-oncogene, GTPase Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

HRas proto-oncogene, GTPase recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human, Mouse, Rat
Application WB, IF, IHC (p), ICC
Validations
  • (4)
  • (8)
N° du produit ABIN2857002
Quantité 100 μL
Fiche technique Fiche technique
Reactivity Human, Mouse, Rat
Application IHC
Validations
  • (5)
N° du produit ABIN7234420
Quantité 200 μL
Fiche technique Fiche technique
Reactivity Human
Application WB, IF, IHC (p)
Validations
  • (2)
  • (4)
N° du produit ABIN392183
Quantité 400 μL
Fiche technique Fiche technique

HRas proto-oncogene, GTPase recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN6967463
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Goat
Analytical Method
Validations
N° du produit ABIN996714
Quantité 96 tests
Fiche technique Fiche technique
Reactivity Dog
Analytical Method Quantitative
Validations
N° du produit ABIN996715
Quantité 96 tests
Fiche technique Fiche technique

HRas proto-oncogene, GTPase recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1307056
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Wheat germ
Validations
  • (1)
N° du produit ABIN1307058
Quantité 10 μg
Fiche technique Fiche technique
Reactivity Human
Source Insect Cells
Validations
  • (1)
N° du produit ABIN3086854
Quantité 1 mg
Fiche technique Fiche technique

Dernières publications sur nos produits HRas proto-oncogene, GTPase

Basu, Lee, Salotti, Basu, Sakchaisri, Xiao, Walia, Westlake, Morrison, Johnson: "Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets." dans: Cancer research, Vol. 78, Issue 4, pp. 891-908, (2019) (PubMed).

Brandt, Albers, Hejhal, Pfundstein, Gonçalves, Catalano, Wild, Frew: "Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma." dans: Oncotarget, Vol. 9, Issue 28, pp. 19753-19766, (2018) (PubMed).

Gao, Wang, Jin, Hu, Duan, Shi, Du, Song, Yang, Li, Han, Zhao, Zhang, Fan, Miao: "Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells." dans: Breast cancer research : BCR, Vol. 20, Issue 1, pp. 112, (2018) (PubMed).

Brandt, Albers, Hejhal, Catalano, Wild, Frew: "Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma." dans: PLoS ONE, Vol. 12, Issue 10, pp. e0186102, (2017) (PubMed).

Ambrosini, Khanin, Carvajal, Schwartz: "Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells." dans: Molecular cancer therapeutics, Vol. 13, Issue 8, pp. 2073-80, (2014) (PubMed).

Maemoto, Yumoto, Ibata, Torizuka, Ozawa, Tatsumi, Hashido, Morikawa, Maeda, Imai: "Mutational analysis of HRAS and KRAS genes in oral carcinoma cell lines." dans: Odontology / the Society of the Nippon Dental University, Vol. 100, Issue 2, pp. 149-55, (2012) (PubMed).

Groesser, Herschberger, Ruetten, Ruivenkamp, Lopriore, Zutt, Langmann, Singer, Klingseisen, Schneider-Brachert, Toll, Real, Landthaler, Hafner: "Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome." dans: Nature genetics, Vol. 44, Issue 7, pp. 783-7, (2012) (PubMed).

Ma, Liu, Wu, Terada: "p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior." dans: Oncogene, Vol. 29, Issue 41, pp. 5559-67, (2010) (PubMed).

Pearl, Prodromou, Workman: "The Hsp90 molecular chaperone: an open and shut case for treatment." dans: The Biochemical journal, Vol. 410, Issue 3, pp. 439-53, (2008) (PubMed).

Millson, Truman, Rácz, Hu, Panaretou, Nuttall, Mollapour, Söti, Piper et al.: "Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates ..." dans: The FEBS journal, Vol. 274, Issue 17, pp. 4453-63, (2007) (PubMed).

Synonymes et noms alternatifs relatifs à HRas proto-oncogene, GTPase

HRas proto-oncogene, GTPase (HRAS), v-Ha-ras Harvey rat sarcoma viral oncogene homolog a (hrasa), neuroblastoma RAS viral (v-ras) oncogene homolog pseudogene (LOC733587), HRas proto-oncogene, GTPase (Hras), Harvey rat sarcoma viral oncogene homolog L homeolog (hras.L), Harvey rat sarcoma viral oncogene homolog (hras), Harvey rat sarcoma virus oncogene (Hras), NRAS proto-oncogene, GTPase (NRAS), -Ha-ras Harvey rat sarcoma viral oncogene homolog b (hrasb), C-BAS/HAS, c-bas/has, C-H-RAS, c-H-ras, c-Ha-ras, C-HA-RAS1, c-rasHa, CTLO, H-RAS, H-Ras, H-ras, H-RASIDX, Ha-ras, HAMSV, Harvey-ras, hras, HRAS, Hras-1, HRAS1, hras1, hrasl, K-RAS, K-Ras, Kras2, N-RAS, N-Ras, ras, RASH1, rash1, zgc:110250, zgc:110734

Protein level used designations for HRas proto-oncogene, GTPase

  • GTP- and GDP-binding peptide B
  • GTPase HRas
  • H-Ras-1
  • Ha-Ras1 proto-oncoprotein
  • Ras family small GTP binding protein H-Ras
  • c-has/bas p21 protein
  • c-ras-Ki-2 activated oncogene
  • p19 H-RasIDX protein
  • p21ras
  • transformation gene: oncogene HAMSV
  • transforming protein p21
  • v-Ha-ras Harvey rat sarcoma viral oncogene homolog
  • xRAS1
  • Transforming protein p21
  • neuroblastoma ras oncogene
  • c-H-ras
  • v-Ha-ras Harvey rat sarcoma viral oncogene-like protein
  • Harvey ras1 protein
  • Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog
  • ras p21
  • small G-protein H-Ras
  • GTPase HRas (Transforming protein p21) (H-Ras-1) (c-H-ras)
  • Harvey ras 1
  • H-ras 1 protein
  • c-Ha-ras p21 protein
  • c-Ha-ras transgene
  • transforming protein P21
  • GTPase NRas
  • transforming protein N-Ras
  • -Ha-ras Harvey rat sarcoma viral oncogene homolog b
  • -Ha-ras Harvey rat sarcoma viral oncogene homolog, like
Vous êtes ici:
Support technique